Next gen medicinal maggot project funded by DARPA

Our application for funding to develop transgenic strains of Lucilia sericata that are engineered to produce and secrete factors to promote wound healing has been funded by DARPA, starting 1 January. The grant will be used to support Dr Rebecca Linger, who was first author on the proof-of-concept paper published in 2016 in BMC Biotechnology.

This entry was posted in NCSU. Bookmark the permalink.